Embryo biopsy harmless -- really

In findings that confirm linkurl:previous ones;http://www.the-scientist.com/news/display/24363/ ultimately dismissed as hype in 2006, scientists have shown that it is possible to create stem cells from an embryo without destroying it. In a linkurl:study;http://images.cell.com/images/EdImages/chung.pdf published online this week in __Cell Stem Cell,__ scientists led by Advanced Cell Technology's Robert Lanza removed one cell from an eight-cell embryo and created viable lines of stem cells. The e

kerry grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
In findings that confirm linkurl:previous ones;http://www.the-scientist.com/news/display/24363/ ultimately dismissed as hype in 2006, scientists have shown that it is possible to create stem cells from an embryo without destroying it. In a linkurl:study;http://images.cell.com/images/EdImages/chung.pdf published online this week in __Cell Stem Cell,__ scientists led by Advanced Cell Technology's Robert Lanza removed one cell from an eight-cell embryo and created viable lines of stem cells. The embryos developed normally for five days after the procedure, which was similar to the single cell biopsy that fertility clinics perform (called preimplantation genetic diagnosis, or PGD). The stem cell lines could retain pluripotency and develop into all three germ layers. Lanza and his colleagues published similar evidence in 2006, but they relied on linkurl:indirect evidence;http://www.the-scientist.com/blog/display/24413 to conclude that the technique was benign. Despite this, a press release from __Nature,__ where the paper was published, and numerous news reports hailed the findings as the ethical antidote to embryonic stem cell research. (Corrections from __Nature's__ press office followed.) In reference to this latest study, Lanza told the linkurl:__Washington Post,__;http://tinyurl.com/2eqg72 "The biopsy had no effect on the embryos' development." I wonder if some of the major news outlets were turned off by the 2006 kerfuffle. These latest data appear much more compelling than those in the 2006 report. Yet some of the major news outlets that covered Lanza's previous findings seemed to have overlooked or ignored this latest study. I called Advanced Cell Technology's press contact just before posting this and will post an update once I hear back from Lanza. UPDATE: I spoke with Robert Lanza about why this latest study didn't appear in __Nature.__ It was not due to the press release problems in the past, he said, and he holds the journal in the highest regard. Rather, "three papers on the same topic in one journal is a little overkill," Lanza said, and that it isn't convention to publish findings that way. Lanza also said the reason he thinks that news outlets didn't cover the __Cell Stem Cell__ paper so heavily is that the findings arent that new. "It's not a question of whether you can remove a cell and have a viable embryo," he said. "We've known that for 10 years."
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours